Hims & Hers Health Inc
NYSE:HIMS
Intrinsic Value
Hims & Hers Health, Inc. operates a telehealth consultation platform. [ Read More ]
The intrinsic value of one HIMS stock under the Base Case scenario is 13.765 USD. Compared to the current market price of 12.595 USD, Hims & Hers Health Inc is Undervalued by 9%.
Valuation Backtest
Hims & Hers Health Inc
Run backtest to discover the historical profit from buying and selling HIMS stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Hims & Hers Health Inc
Current Assets | 265.1m |
Cash & Short-Term Investments | 221m |
Receivables | 5.7m |
Other Current Assets | 38.4m |
Non-Current Assets | 176.1m |
PP&E | 45.7m |
Intangibles | 129.5m |
Other Non-Current Assets | 947k |
Current Liabilities | 88.5m |
Accounts Payable | 43.1m |
Accrued Liabilities | 28.2m |
Other Current Liabilities | 17.2m |
Non-Current Liabilities | 8.7m |
Other Non-Current Liabilities | 8.7m |
Earnings Waterfall
Hims & Hers Health Inc
Revenue
|
872m
USD
|
Cost of Revenue
|
-157.1m
USD
|
Gross Profit
|
714.9m
USD
|
Operating Expenses
|
-741m
USD
|
Operating Income
|
-26m
USD
|
Other Expenses
|
2.5m
USD
|
Net Income
|
-23.5m
USD
|
Free Cash Flow Analysis
Hims & Hers Health Inc
HIMS Profitability Score
Profitability Due Diligence
Hims & Hers Health Inc's profitability score is 33/100. The higher the profitability score, the more profitable the company is.
Score
Hims & Hers Health Inc's profitability score is 33/100. The higher the profitability score, the more profitable the company is.
HIMS Solvency Score
Solvency Due Diligence
Hims & Hers Health Inc's solvency score is 78/100. The higher the solvency score, the more solvent the company is.
Score
Hims & Hers Health Inc's solvency score is 78/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
HIMS Price Targets Summary
Hims & Hers Health Inc
According to Wall Street analysts, the average 1-year price target for HIMS is 16.026 USD with a low forecast of 11.11 USD and a high forecast of 21 USD.
Ownership
HIMS Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
HIMS Price
Hims & Hers Health Inc
Average Annual Return | -0.98% |
Standard Deviation of Annual Returns | 47.22% |
Max Drawdown | -87% |
Market Capitalization | 2.7B USD |
Shares Outstanding | 214 250 000 |
Percentage of Shares Shorted | 8.12% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Hims & Hers Health, Inc. operates a telehealth consultation platform. The company is headquartered in San Francisco, California and currently employs 398 full-time employees. The company went IPO on 2019-09-09. The firm has designed and build a cloud-based technology, through which it offers a range of health and wellness products and services. Its platform helps customers to access medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more. The firm has partnered with dermatology experts to offer access to formulated topical creams for customers experiencing acne and signs of premature aging, such as wrinkles. The company offers telehealth solutions with combined access to a distributed provider network, digital prescriptions, cloud pharmacy, and consumer engagement strategies, all delivered through mobile and Web interfaces. The firm's Products include shampoo, conditioner, biotin gummies, anti-aging cream, vitamin c serum, acne cream and moisturizer.
Contact
IPO
Employees
Officers
The intrinsic value of one HIMS stock under the Base Case scenario is 13.765 USD.
Compared to the current market price of 12.595 USD, Hims & Hers Health Inc is Undervalued by 9%.